[1] Maeda O, Ando Y. Recent progress of chemotherapy and biomarkers for gastroesophageal cancer[J].World J Gastrointest Oncol, 2019, 11(7):518-526.
[2] 余晶平,杨 波,孟彦红.奥沙利铂联合氟尿嘧啶治疗老年晚期胃癌42例[J].武警医学,2017,28(6):635-636.
[3] Matsuoka T, Yashiro M. Biomarkers of gastric cancer: current topics and future perspective[J].World J Gastroenterol, 2018, 24(26):2818-2832.
[4] 徐正水,程 华.血常规对胃癌的预后的评估价值的研究进展[J].中华胃肠外科杂志,2017,20(2):236-240.
[5] Giese M, Hind L, Huttenlocher A. Neutrophil plasticity in the tumor microenvironment[J].Blood, 2019,133(20):2159-2167.
[6] Deryugina E I, Zajac E, Juncker J A,et al. Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment[J]. Neoplasia, 2014, 16 (10):771-788.
[7] Camso R A,Bellocco R,Pagano M,et al.Prognostic value of intratumoml neutmphils in advanced gastric carcinoma in a high-risk area in northern Italy[J].Mod Pathol, 2015,15(8):831-837.
[8] Donskov F.Immunomonitoring and prognostic relevance of neutrophils in clinical trials[J].Semin Cancer Biol,2016,23(3):200-207.
[9] Ocana A, Nieto J C, Pandiella A,et al.Neutrophils in cancer: prognostic role and therapeutic strategies[J]. Mol Cancer, 2017, 16(1):137-145.
[10] Zhang W, Gu J, Chen J,et al. Interaction with neutrophils promotes gastric cancer cell migration and invasion by inducing epithelial-mesenchymal transition[J]. Oncol Rep, 2017, 38(5):2959-2966.
[11] Chen Z, Chen W, Wang J, et al. Pretreated baseline neutrophil count and chemotherapy-induced neutropenia may be conveniently available as prognostic biomarkers in advanced gastric cancer[J]. Intern Med J, 2015,45(8):854-859.
[12] Zhao J J,Pan K,Wang W,et al.The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection[J].PLoS One, 2012,7(3):33655-33662.
[13] 王婷婷,庄 园,陈 娜,等.肿瘤相关中性粒细胞在胃癌中的分布、表型及其免疫抑制功能研究[J].第三军医大学学报,2014,36(6):587-591.
[14] Wang S C, Chou J F, Strong V E, et al. Pretreatment neutrophil to lymphocyte ratio independently predicts disease-specific survival in Resectable gastroesophageal junction and gastric adenocarcinoma[J]. Ann Surg, 2016, 263(2):292-297.
[15] Eriksen A C, S rensen F B, Lindebjerg J, et al. The prognostic value of tumor-infiltrating lymphocytes in stage II Colon Cancer. A Nationwide population-based study[J]. Transl Oncol, 2018,11(4):979-987.
[16] Pirozzolo G, Gisbertz S S, Castoro C,et al. Neutrophi to lymphocyte ratio as prognostic marker in gastric cancer: a systematic review and meta- analysis[J]. J Thorac Dis,2019,11(7):3136-3145.
[17] Feng F,Zheng G,Wang Q, et al. Low lymphocyte count and high monocyte count predicts poor prognosis of gastric cancer[J].BMC Gastroenterol,2018, 18(1):148-156.
[18] Jiang N, Deng J Y, Liu Y,et al. The role of preoperativeneutrophil-lymphocyte and plateletlymphocyteratio in patients after radical resection for gastriccancer[J]. Biomarkers, 2014,19(6):444-451.
[19] Cho I R, Park J C, Park C H,et al, Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker topredict chemotherapeutic response and survival outcomes inmetastatic advanced gastric cancer[J]. Gastric Cancer, 2014, 17(4):703-710.
[20] 贾 静,陈 颖,林 露,等.胃癌患者术前NLR PLR RDW值与病理参数的关系[J].中国肿瘤临床,2017,44(2):78-82.
[21] Graziosi L, Marino E, Angelis V, et al. Prognostic value of preoperative neutrophilsto lymphocytes ratio in patients resected for gastriccancer[J]. Am J Surg, 2016,209(2):333-337.
[22] 邓显伦,冯立波,徐建伟,等.胃癌患者外周血常规指标与肿瘤淋巴结转移关系分析[J].重庆医学,2018,47(9):1266-1268.
[23] 郭旭利,李 俊,郭晓红.NLR预测进展期胃癌化疗疗效的临床价值[J].华夏医学,2018,31(2):62-65.
[24] Hirahara T, Arigami T, Yanagita S et al,Combined neutrophil lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer[J]. BMC Cancer, 2019, 19 (1) :672-683.
[25] Hsu J T, Liao C K, Le P H, et al. Prognostic value of the preoperative neutrophil to lymphocyte ratio in resectable gastric cancer[J]. Medicine (Baltimore), 2015, 94(39):1589-1594.
[26] Aldemir M N, Turkeli M, Simsek M, et al. Prognostic value of baseline neutrophil lymphocyte and platelet lymphocyte ratios in local and advanced gastric cancer patients[J]. Asian Pac J Cancer Prev, 2015,16(14):5933-5937.
[27] Wang D S, Ren C,Qiu M Z, et al. Comparison of the prognostic value of various preoperative inflammation based factors in patients with stage III gastric cancer[J]. Tumour Biol, 2015, 33(3):749-756.